Deep dives into polymer design, mechanobiology, and translational tissue engineering for researchers and clinicians shaping the future of implantable therapeutics.
You're staring at a fatigue curve. 1,000 cycles — the lab says the scaffold should still be within 90% of original stiffness. But on site, the drift s...
Tissue engineering promises to rebuild what the body cannot. But before you get to the elegant bioreactor or the clever growth factor delivery system,...
If you are reading this, you probably already know the elevator pitch: biomaterials plus cells equals replacement tissue. Simple, right? But the gap b...
You've spent weeks tuning electrospinning parameters or porogen leaching. Final scaffolds come out of the vacuum oven. You image them—and the pores ar...
You synthesized a pH-responsive theranostic scaffold that lit up perfectly at pH 6.8. Six month later, the same scaffold barely flickers at pH 6.5. Wh...
Chronic immune drift is the slow, cumulative shift in immune state over months to years. It happens in aging, chronic infection, autoimmune progressio...
You have a theranostic coating that releases drug like a burst—and the diagnostic signal crawls behind like a reluctant witness. The mismatch is not j...
Imagine a smart bandage that only releases antibiotics when both bacterial enzymes and low pH are present — a classic dual-trigger theranostic interfa...
If you are building a vascularized organoid, you have two starkly different ways to get blood vessels in. Let the endothelial cells self-organize into...
You have spent months coaxing stem cells into a miniature liver. The organoid looks good. Then you hook up the flow. Twenty-four hours later, the pare...
Picture this: Tuesday afternoon, you check the confocal stack of your day-14 vascularized organoid. The vessel front—that leading edge of CD31-positiv...
You grow a beautiful vascularized organoid. Bright red lectin staining, nice branching. Then you add a drug and the whole thing lights up like a Chris...